Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Legal / IP
Biocytogen’s RenMab Platform Wins Japanese Patent, Expanding IP Portfolio
June 6, 2025
Company
Deals
Bayer’s Vividion Gains Global Rights to WRN Inhibitor VVD-214
June 6, 2025
Company
Deals
Nanjing Leads Biolabs Files for Hong Kong IPO Amid Product Pipeline Progress
June 6, 2025
Company
Medical Device
Acotec Scientific Gains NMPA Approval for AcoArt Verbena Vertebral Balloon
June 6, 2025
Company
Drug
Hengrui Pharmaceuticals Gains NMPA Approval for Phase Ib/II Study of SHR-A1811, Adebrelimab and Famitinib in Solid Tumors
June 6, 2025
Company
Deals
Qure Biotechnology Secures RMB 100 Million Series C1 Financing
June 6, 2025
Company
Drug
Lianhuan Pharma Gains NMPA Approval for No-Spa Generic
June 6, 2025
Company
Drug
Roche’s Evrysdi 5mg Tablet Gains EU Commission Approval for Spinal Muscular Atrophy
June 6, 2025
Company
Deals
Shanghai OPM Biosciences Plans Acqusition of PharmaLegacy Labs for RMB 1.45 Billion
June 6, 2025
Company
Drug
Sunshine Guojian’s SSGJ-613 Meets Phase III Endpoints in Acute Gouty Arthritis
June 6, 2025
Policy / Regulatory
NHSA Strengthens Pharmaceutical Pricing and Procurement Credit Evaluation Mechanism
June 6, 2025
Policy / Regulatory
China Issues Whistleblower Incentives for Drug and Medical Device Safety Violations
June 6, 2025
1
2
…
21
22
23
24
25
…
27
28
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
